We are live on
!
Find out more
TCA
Transcend Capital Advisors Portfolio holdings
AUM
$1.48B
1-Year Est. Return
25.55%
This Fund
S&P 500
This Quarter
Est. Return
+9.86%
1 Year Est. Return
+25.55%
3 Year Est. Return
+71.65%
5 Year Est. Return
+78.2%
10 Year Est. Return
–
AUM
$371M
AUM Growth
–
Cap. Flow
+$353M
Cap. Flow
% of AUM
94.97%
Top 10 Holdings %
Top 10 Hldgs %
29.81%
Holding
211
New
211
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$24.5M |
| 2 |
Apple
AAPL
|
+$22.5M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$11.6M |
| 4 |
Blackstone
BX
|
+$8.22M |
| 5 |
ExxonMobil
XOM
|
+$6.8M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 29.72% |
| 2 | Healthcare | 18.09% |
| 3 | Technology | 13.28% |
| 4 | Financials | 12.21% |
| 5 | Consumer Staples | 6.36% |
Similar funds
AE
HMH
CFIA
FA
WAG
SI
PIA
TAM
Transcend Capital Advisors's Q4 2019 Portfolio in Review
Q4 2019 is the first quarter with a 13F filing on record for Transcend Capital Advisors, which disclosed 211 positions worth $371M. Its ten largest holdings account for 30% of the portfolio.
Its largest position is Merck: 298,365 shares worth $25.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, followed by Healthcare and Technology.
- Transcend Capital Advisors's largest Q4 2019 buy was Merck: 298,365 shares worth $25.9M.
- Transcend Capital Advisors's ten largest holdings make up 30% of its $371M portfolio in Q4 2019.
- Transcend Capital Advisors disclosed 211 positions in Q4 2019, its first 13F filing on record.
Based on Transcend Capital Advisors's 13F filing for Q4 2019, filed 19 Feb 2020.